Drug-resistant tuberculosis treatment

Description

This e-learning course is a comprehensive, self-paced, online course that follows the content of the WHO operational handbook on tuberculosis. Module 4: Treatment – drug-resistant tuberculosis treatment. The main focus of the e-course is programmatic; clinical aspects are only discussed when relevant to specific topics.

The e-course comprises 11 sections and a final assessment and uses a combination of short video lectures, exercises, quiz questions and additional reading materials.

Course Index:

  1. Introduction to the e-learning course
  2. Rationale for national TB programmes to implement and scale up treatment of DR-TB
  3. Key considerations in DR-TB treatment
  4. Treatment regimen for isoniazid-resistant rifampicin-susceptible TB
  5. Shorter, all-oral bedaquiline-containing treatment regimen
  6. Longer treatment regimens for multidrug-resistant TB (MDR-TB)/ rifampicin-resistant TB (RR-TB)
  7. The bedaquiline, pretomanid and linezolid (BPaL) regimen for MDR-TB or RR-TB with additional fluoroquinolone resistance 
  8. Adjuncts to MDR-TB treatment
  9. Patient support to enable adherence to treatment
  10. Programmatic implementation of regimens for MDR-TB and RR-TB 
  11. Assessing drug-resistant TB programme implementation effectiveness 
  12. Final assessment